Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 337 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is K  [Clear All Filters]
2007
Guo XV, Monteleone M, Klotzsche M, Kamionka A, Hillen W, Braunstein M, Ehrt S, Schnappinger D.  2007.  Silencing Mycobacterium smegmatis by using tetracycline repressors.. J Bacteriol. 189(13):4614-23.
Guo XV, Monteleone M, Klotzsche M, Kamionka A, Hillen W, Braunstein M, Ehrt S, Schnappinger D.  2007.  Silencing Mycobacterium smegmatis by using tetracycline repressors.. J Bacteriol. 189(13):4614-23.
Dey AK, David KB, Klasse PJ, Moore JP.  2007.  Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1.. Virology. 360(1):199-208.
2006
Tripathi P, Madan R, Chougnet C, Divanovic S, Ma X, Wahl LM, Gajewski T, Karp CL, Hildeman DA.  2006.  An adenoviral vector for probing promoter activity in primary immune cells.. J Immunol Methods. 311(1-2):19-30.
Kathpalia VP, Mussak EN, Chow SS, Lam PH, Skelley N, Time M, Markelewicz RJ, Kanduc D, Lomas L, Xiang Z et al..  2006.  Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures.. J Dermatol. 33(5):309-18.
Kathpalia VP, Mussak EN, Chow SS, Lam PH, Skelley N, Time M, Markelewicz RJ, Kanduc D, Lomas L, Xiang Z et al..  2006.  Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures.. J Dermatol. 33(5):309-18.
Anand VK, Kacker A, Orjuela AF, Huang C, Manarey C, Xiang JZ.  2006.  Inflammatory pathway gene expression in chronic rhinosinusitis.. Am J Rhinol. 20(4):471-6.
Kojic M, Zhou Q, Lisby M, Holloman WK.  2006.  Rec2 interplay with both Brh2 and Rad51 balances recombinational repair in Ustilago maydis.. Mol Cell Biol. 26(2):678-88.
Chung EY, Kim SJung, Ma XJing.  2006.  Regulation of cytokine production during phagocytosis of apoptotic cells.. Cell Res. 16(2):154-61.
Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F et al..  2006.  Relationship of gene expression and chromosomal abnormalities in colorectal cancer.. Cancer Res. 66(4):2129-37.
Shimosato T, Kimura T, Tohno M, Iliev ID, Katoh S, Ito Y, Kawai Y, Sasaki T, Saito T, Kitazawa H.  2006.  Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure.. Cell Microbiol. 8(3):485-95.
Shimosato T, Kimura T, Tohno M, Iliev ID, Katoh S, Ito Y, Kawai Y, Sasaki T, Saito T, Kitazawa H.  2006.  Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure.. Cell Microbiol. 8(3):485-95.
Shimosato T, Kimura T, Tohno M, Iliev ID, Katoh S, Ito Y, Kawai Y, Sasaki T, Saito T, Kitazawa H.  2006.  Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure.. Cell Microbiol. 8(3):485-95.
Shimosato T, Kimura T, Tohno M, Iliev ID, Katoh S, Ito Y, Kawai Y, Sasaki T, Saito T, Kitazawa H.  2006.  Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure.. Cell Microbiol. 8(3):485-95.
2005
Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.  2005.  Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.. Biochem Biophys Res Commun. 326(4):782-7.
Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.  2005.  Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.. Biochem Biophys Res Commun. 326(4):782-7.
Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.  2005.  Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.. Biochem Biophys Res Commun. 326(4):782-7.
Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.  2005.  Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.. Biochem Biophys Res Commun. 326(4):782-7.
Kojic M, Zhou Q, Lisby M, Holloman WK.  2005.  Brh2-Dss1 interplay enables properly controlled recombination in Ustilago maydis.. Mol Cell Biol. 25(7):2547-57.
Kim S, Chung EY, Ma X.  2005.  Immunological consequences of macrophage-mediated clearance of apoptotic cells.. Cell Cycle. 4(2):231-4.
Liu J, Cao S, Kim S, Chung EY, Homma Y, Guan X, Jimenez V, Ma X.  2005.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.. Curr Immunol Rev. 1(2):119-137.
Zhou XW, Kafsack BFC, Cole RN, Beckett P, Shen RF, Carruthers VB.  2005.  The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins.. J Biol Chem. 280(40):34233-44.
Nathan C, Calingasan N, Nezezon J, Ding A, M Lucia S, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NSoo et al..  2005.  Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.. J Exp Med. 202(9):1163-9.
Nathan C, Calingasan N, Nezezon J, Ding A, M Lucia S, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NSoo et al..  2005.  Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.. J Exp Med. 202(9):1163-9.
Veazey RS, Springer MS, Marx PA, Dufour J, Klasse PJohan, Moore JP.  2005.  Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.. Nat Med. 11(12):1293-4.